Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ...

Oruka Therapeutics, Inc. has surged after ORKA-001 showed a half-life four times that of Skyrizi in Phase 1, targeting the ...

An increase in the proportion of plant-based foods in the diet may be associated with a decrease in the severity of psoriasis symptoms. This conclusion was reached by researchers from King's College ...

Consuming a greater proportion of nutrients from plant sources may aid management of psoriasis symptoms, according to a study published online Feb. 19 in the European Journal of Nutrition.

Evidence from multiple trials links weight loss with milder symptoms and improved wellbeing in people with psoriasis.

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

Patients with psoriasis were associated with significantly lower circulating BDNF levels compared with healthy control individuals.

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...

“In my experience and personally managing my own psoriasis, I’ve found consistent red-light therapy helps to reduce redness, soothe irritation, and support the skin’s recovery during flare-ups. While ...

Portia has not taken Sotyktu. Portia Brown* has long been drawn toward helping people cope with challenges. Since volunteering as a college student to work with her peers to educate them about sexual ...